Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Nebius (NEBIUS) appears to be trading on momentum and narrative gaps rather than underlying business progress. With no options market and limited public disclosure, the risk/reward favors a measured short. This trade idea lays out a concrete entry at $6.50, an immediate stop at $9.00, and a primary target of $3.50 across a 45-trading-day swing hori…
Keurig Dr Pepper reported quarterly results that surpassed expectations and raised its annual revenue guidance, attributing momentum to strong consumer demand for its carbonated soft drinks and energy offerings, new flavor introductions and targeted marketing. The company is also progressing on financing for its planned acquisition of JDE Peet's an…
Chicago Federal Reserve Bank President Austan Goolsbee signaled that the central bank could resume lowering interest rates if inflation returns toward target, but cautioned against loosening policy now based on hopes for rising productivity. He warned that premature cuts risk stoking overheating if investment-driven productivity gains do not materi…
Lawrence B. Seidman, a director of Bankwell Financial Group, Inc. (NASDAQ: BWFG), executed six sales of common stock on February 23, 2026, totaling $473,962. The shares changed hands at prices between $47.39 and $47.42. Despite the sale, Seidman retains significant direct and indirect holdings across multiple entities. Separately, Bankwell reported…
Morgan Stanley upgraded Booking Holdings to overweight from equal-weight in a note on Tuesday, assigning a $5,500 price target, down from $6,150. Analyst Brian Nowak argued Booking’s ability to own the customer, gather traveler data and convert that into high-margin direct business should preserve its central role in travel even as agentic tools de…
Goldman Sachs projects U.S. GDP will accelerate in 2026 above consensus, driven by tax cuts, a fading tariff drag and easier financial conditions that should bolster business investment. The bank flags a sharp equity correction, AI-related labor disruptions and consumer-facing tariff pass-throughs as the key downside risks that could trim growth.
UBS Global Research downgraded Gerresheimer AG (ETR:GXIG) from "neutral" to "sell" and reduced its 12-month price target to €12.90 from €29, citing elevated leverage, lower growth and weaker margin assumptions. The broker highlighted unclear covenant terms after a debt renegotiation and noted the company has started sale processes for Centor and Mo…
Tesla is actively shifting capital and strategic focus away from legacy vehicle profit-per-unit toward recurring, software-driven revenue streams anchored by Dojo, FSD/robotaxi, and energy/software services. This trade buys that transition at a tactical entry with defined stop and ambitious target that prices in accelerating AI monetization.
A Reuters poll of market analysts and strategists finds European stocks have enjoyed a robust start to 2026 but are forecast to slip in mid-year before finishing the year only marginally higher. The STOXX 600 is seen reaching 640 by end-2026, reflecting modest gains from current levels as investors weigh geopolitical risks, tariff developments and …
Needham reduced its price target on EverQuote (EVER) to $25 from $40 while keeping a Buy rating after the insurtech reported record fourth-quarter results and provided first-quarter guidance below consensus. The company posted strong Q4 metrics driven by increased carrier spending, reiterated a plan to reach $1 billion in revenue within two to thre…
Hims & Hers Health saw its shares fall 7.4% to $14.40 in premarket trading after the company issued a first-quarter revenue forecast below analyst expectations. Management cited regulatory pressure tied to its weight-loss offerings and higher spending on international expansion. Several Wall Street firms reacted with downgrades, lower price targets…
U.S. stock futures inched higher Tuesday following a prior session selloff, with investors parsing uncertainty around global trade and concerns about AI-driven disruption. Corporate reports and company-specific developments pushed a number of names in premarket trading: Home Depot, Keurig Dr Pepper and AMD posted notable gains, while Novo Nordisk, …
German Chancellor Friedrich Merz makes his first trip to China as chancellor leading a delegation of top business executives amid mounting economic tensions. The visit, which includes meetings with President Xi Jinping and Premier Li Qiang and stops at industry sites, seeks to secure economic agreements while German firms confront intense competiti…
AES Corp has entered a 20-year agreement to provide electricity to Google’s forthcoming data center in Wilbarger County, Texas. The pact includes construction of generation resources co-located with the facility and shared grid infrastructure to support Google’s expansion. The announcement came as AES stock ticked higher in premarket trade and foll…
Agillic A/S has provided guidance for 2026 that calls for subscription annual recurring revenue (ARR) growth of 5% to 10%, an EBITDA margin between 12% and 18%, and the generation of positive free cash flow. The company reported 2025 subscription ARR of DKK 56.7 million, total revenue of DKK 58.4 million and EBITDA of DKK 8.4 million, up from DKK 1…
Wedbush downgraded Gossamer Bio to Neutral from Outperform and trimmed its price target to $1.00 from $6.00 after the company’s Phase 3 PROSERA trial did not meet its primary endpoint. The firm extended expected launch timing to fiscal 2028, narrowed the market opportunity, raised its discount rate to 40%, and highlighted the need to address conver…
Needham has raised its price target on Vir Biotechnology to $18 from $14 and kept a Buy rating after updated Phase 1 dose-escalation data for VIR-5500 showed clinical activity in metastatic castration-resistant prostate cancer. The company has also struck a commercialization pact with Astellas, and other firms have responded with upgrades and highe…
FBN Securities has initiated coverage of SailPoint Technologies (SAIL) with an Outperform rating and an $18 price target, noting the company’s leadership in Identity Governance and Administration and recent revenue momentum. The stock is trading near its 52-week low, and a separate BTIG note maintained a Buy rating with a $29 target following meeti…
Needham reduced its price target for Backblaze Inc. (BLZE) to $6.00 from $8.00 but left its Buy rating intact. The firm cited compressed software multiples and a pullback in B2 Cloud growth versus guidance, even as Backblaze reported an earnings beat for Q4 2025 and closed a $15 million, three-year white-label storage deal. Analysts' targets span f…
Guggenheim reduced its price target on Spotify to $600 from $720 but retained a Buy rating, citing updated margin assumptions and a higher risk premium in its discounted cash flow work. The firm's modeling changes also revise forecasts for Universal Music Group ahead of its March 5 earnings, and several other brokerages have issued varied ratings a…
Mexico's annual inflation rose to 3.92% in the first half of February, slightly above economists' expectations, while core inflation climbed to 4.52%, remaining well above the central bank's 3% target range. The data reduces the likelihood of an interest rate cut at the next policy meeting after Banxico's pause earlier this month.
Guggenheim reduced its price target for Claritev (CTEV) to $38 from $43 while retaining a Buy rating after the company reported fourth-quarter fiscal 2025 results that modestly beat consensus on revenue and EBITDA. The firm flagged slightly softer 2026 guidance and margin headwinds tied to conservative assumptions and incremental investments in M&A…
Guggenheim reduced its price target on StubHub Holdings to $9.00 from $16.00 while retaining a Buy rating, citing regulatory proposals in the UK, California and New York and pressures in the concert secondary market in the U.S. The firm trimmed 2026 and 2027 adjusted EBITDA forecasts, leaving consensus estimates notably higher. StubHub’s recent com…
Saudi Arabia's equity market closed lower on Tuesday, with the Tadawul All Share slipping 0.71% to a new one-month low. Sector losses in Media & Publishing, Hotels & Tourism and Building & Construction weighed on the market, while individual winners and losers produced sizable percentage swings. Commodity and currency benchmarks showed mixed moveme…
Eli Lilly shares fell about 2.2% Tuesday after reports that Novo Nordisk will cut U.S. list prices for its GLP-1 drugs, including Ozempic and Wegovy, by up to 50% starting Jan. 1, 2027. Novo Nordisk shares also declined roughly 3%. The announced price changes are intended to lower costs for patients with high deductibles or coinsurance tied to list…
